YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials

Rengui Zhang, Jin Wang, Xuejie Zhang


Abstract
This paper describes the system for the YNU-HPCC team for SemEval2024 Task 2, focusing on Safe Biomedical Natural Language Inference for Clinical Trials. The core challenge of this task lies in discerning the textual entailment relationship between Clinical Trial Reports (CTR) and statements annotated by expert annotators, including the necessity to infer the relationships in texts subjected to semantic interventions accurately. Our approach leverages a fine-tuned DeBERTa-v3-large model augmented with supervised contrastive learning and back-translation techniques. Supervised contrastive learning aims to bolster classification ac-curacy while back-translation enriches the diversity and quality of our training corpus. Our method achieves a decent F1 score. However, the results also indicate a need for further en-hancements in the system’s capacity for deep semantic comprehension, highlighting areas for future refinement. The code of this paper is available at:https://github.com/RGTnuw/RG_YNU-HPCC-at-Semeval2024-Task2.
Anthology ID:
2024.semeval-1.112
Volume:
Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)
Month:
June
Year:
2024
Address:
Mexico City, Mexico
Editors:
Atul Kr. Ojha, A. Seza Doğruöz, Harish Tayyar Madabushi, Giovanni Da San Martino, Sara Rosenthal, Aiala Rosá
Venue:
SemEval
SIG:
SIGLEX
Publisher:
Association for Computational Linguistics
Note:
Pages:
785–791
Language:
URL:
https://aclanthology.org/2024.semeval-1.112
DOI:
Bibkey:
Cite (ACL):
Rengui Zhang, Jin Wang, and Xuejie Zhang. 2024. YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials. In Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024), pages 785–791, Mexico City, Mexico. Association for Computational Linguistics.
Cite (Informal):
YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials (Zhang et al., SemEval 2024)
Copy Citation:
PDF:
https://preview.aclanthology.org/jeptaln-2024-ingestion/2024.semeval-1.112.pdf
Supplementary material:
 2024.semeval-1.112.SupplementaryMaterial.txt
Supplementary material:
 2024.semeval-1.112.SupplementaryMaterial.zip